Skip to search formSkip to main contentSkip to account menu

INT 747

Known as: INT-747, INT747 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The farnesoid X receptor (FXR) agonist, a bile acid‐activated nuclear receptor, has been shown to improve the histologic features… 
2016
2016
Aim:Sweroside is an iridoid glycoside with diverse biological activities. In the present study we investigated the effects of… 
2013
2013
Aims Genetic and pharmacological studies have shown that impairment of the nitric oxide (NO) synthase (NOS) pathway is associated… 
Highly Cited
2012
Highly Cited
2012
Metabolic syndrome (MetS) and benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS) are often associated. One of… 
2011
2011
Bile salts are produced in the liver and delivered to the duodenum, where they emulsify lipids to facilitate absorption. After… 
Highly Cited
2011
Highly Cited
2011
INTRODUCTION The farnesoid X receptor (FXR) is critically involved in the regulation of the hepato-biliary system. Recent data… 
Highly Cited
2010
Highly Cited
2010
Two dedicated receptors for bile acids (BAs) have been identified, the nuclear hormone receptor farnesoid X receptor (FXR) and… 
Highly Cited
2010
Highly Cited
2010
Rationale: Vascular calcification is highly associated with cardiovascular morbidity and mortality, especially in patients with… 
Highly Cited
2005
Highly Cited
2005
The farnesoid X receptor (FXR), an endogenous sensor for bile acids, regulates a program of genes involved in bile acid…